[Expression of a gene encoding the porcine rotavirus VP7 capsid using a nondefective recombinant adenoviral genome]. 1995

K K Doronin, and G K Iurov, and N F Grinenko, and A N Zakharchuk, and T S Denisova, and T M Baburina, and V A Krugliak, and B S Naroditskiĭ

A nondefective recombinant human adenovirus 5 (Ad5) carrying the gene encoding for the porcine rotavirus outer capsid protein VP7 in the E3 region of the Ad5 genome has been obtained. mRNA for VP7 in recombinant Ad5KV14/VP7 infected cells was demonstrated by means of RT-PCR. Radioimmunoprecipitation of cell extracts infected with Ad5KV14/VP7 on early (12 h p.i.) and late (24 h p.i.) stages of adenovirus infection with rabbit polyclonal antiserum raised to purified rotavirus virions revealed a recombinant protein possessing the same electrophoretic mobility, 37 kDa, as the native rotavirus K VP7. One-dimensional peptide mapping also demonstrated the identity of the recombinant and native VP7.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

K K Doronin, and G K Iurov, and N F Grinenko, and A N Zakharchuk, and T S Denisova, and T M Baburina, and V A Krugliak, and B S Naroditskiĭ
November 2008, Wei sheng wu xue bao = Acta microbiologica Sinica,
K K Doronin, and G K Iurov, and N F Grinenko, and A N Zakharchuk, and T S Denisova, and T M Baburina, and V A Krugliak, and B S Naroditskiĭ
June 1994, Journal of virology,
K K Doronin, and G K Iurov, and N F Grinenko, and A N Zakharchuk, and T S Denisova, and T M Baburina, and V A Krugliak, and B S Naroditskiĭ
January 1988, Nucleic acids research,
K K Doronin, and G K Iurov, and N F Grinenko, and A N Zakharchuk, and T S Denisova, and T M Baburina, and V A Krugliak, and B S Naroditskiĭ
June 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases,
K K Doronin, and G K Iurov, and N F Grinenko, and A N Zakharchuk, and T S Denisova, and T M Baburina, and V A Krugliak, and B S Naroditskiĭ
November 1992, Virus genes,
K K Doronin, and G K Iurov, and N F Grinenko, and A N Zakharchuk, and T S Denisova, and T M Baburina, and V A Krugliak, and B S Naroditskiĭ
June 2009, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
K K Doronin, and G K Iurov, and N F Grinenko, and A N Zakharchuk, and T S Denisova, and T M Baburina, and V A Krugliak, and B S Naroditskiĭ
January 2019, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology],
K K Doronin, and G K Iurov, and N F Grinenko, and A N Zakharchuk, and T S Denisova, and T M Baburina, and V A Krugliak, and B S Naroditskiĭ
April 2018, Pathogens (Basel, Switzerland),
K K Doronin, and G K Iurov, and N F Grinenko, and A N Zakharchuk, and T S Denisova, and T M Baburina, and V A Krugliak, and B S Naroditskiĭ
January 2012, Iranian journal of public health,
K K Doronin, and G K Iurov, and N F Grinenko, and A N Zakharchuk, and T S Denisova, and T M Baburina, and V A Krugliak, and B S Naroditskiĭ
January 1991, The Journal of general virology,
Copied contents to your clipboard!